Beacon Orthopaedics & Sports Medicine in Sharonville, Ohio, is providing Regenexx regenerative medicine treatments as an alternative to orthopedic surgery, reports WCPO.

California voters are wrestling with the question of whether to support a ballot initiative that will grant the Oakland-based California Institute for Regenerative Medicine another $5.5 billion to continue its research-funding efforts, the Sacramento Business Journal reports.

Sarasota, Fla.-based Bennett Orthopedics and Sportsmedicine is providing patients access to stem cell treatments to address pain.

Researchers at Troy, N.Y.-based Rensselaer Polytechnic Institute designed a biomaterial that could provide targeted treatment to injured spinal cords and tissue to prevent additional damage, reports Sci Tech Daily.

Seven former Osteo Relief Institutes and their owners will pay millions of dollars to settle fraud allegations.

LifeNet Health opened a regenerative medicine logistics and distribution facility in Indianapolis on Oct. 15.

MedTech Outlook Magazine recognized Biologica Technologies as one of the Top 10 MedTech Startups in 2019.

Four medical facilities in the U.S. are engaging in a $13 million clinical trial to study stem cell treatment for osteoarthritis in the knee, reports WKRG.

Bioventus launched a disease and product information website called OAKneePainRelief.com to provide information on knee osteoarthritis for patients and providers.

Orthocell noted positive interim clinical results for CelGro, its collagen-based scaffold to support tissue growth and repair, reports Small Caps.

At the North American Spine Society Annual Meeting, in a Sept. 25 panel session titled "BMP in 2019 – The Biologic Hasn't Changed but the Evidence Has," a group of physicians discussed the state of BMP today.

Stem cell-focused oncology company Vor Biopharma made a series of appointments to its leadership team.

The Spine Journal, the official journal of the North American Spine Society, published a DiscGenics study examining preclinical testing for Discogenic Cells, reports OA Online.

Rosalind Franklin University's Chicago Medical School recognized Wayne Olan, MD, as a distinguished alumnus.

Royal Biologics recently launched the Maxx Ultra Cord with clinical applications in spine and neurosurgery.

Drug company Catalent named David Schaffer, PhD, to its biologics advisory board.

Google will no longer allow advertisements for unproven or experimental medical procedures in its search results to prevent clinics from misleading patients, The Verge reports.

Here are four treatments that are in development in the biologics space:

Drugmakers Grünenthal and Mesoblast entered into a partnership to develop a biologics-based treatment for chronic lower back pain.

NervGen Pharma is planning its clinical development strategy for its compound, NVG-291, in spinal cord injury and multiple sclerosis patients.